Covid-19 Research

Review Article

Systemic Lupus Erythematosus: Clinical, Diagnostic, and Therapeutic Perspectives

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Review Article
Subject Medicine Group
OCLC JBRES Record
Bergamaschi MM
Issue: Volume7-Issue1
Pages: 1-11
Received: 2025-12-25
Accepted: 2026-01-26
Published: 2026-01-28

Abstract

Background: Systemic Lupus Erythematosus is a chronic autoimmune disease with systemic involvement, predominantly affecting women of reproductive age. Its development is related to genetic, hormonal, and environmental factors that lead to immune dysregulation and loss of tolerance to self-antigens. Cutaneous manifestations are common, especially photosensitivity and acute cutaneous lesions, such as the malar rash. Due to its heterogeneous clinical presentation, diagnosis and management remain challenging.
Methods: This narrative review synthesizes current evidence from books and scientific articles retrieved from the Scientific Electronic Library Online, PubMed, and MEDLINE databases. The search was conducted using standardized terminology related to Systemic Lupus Erythematosus, focusing on pathophysiology, clinical manifestations, diagnostic criteria, and therapeutic approaches.
Results: The analysis highlights that Systemic Lupus Erythematosus presents a wide range of clinical manifestations, affecting the skin, joints, kidneys, and other organs. Diagnosis relies on the integration of clinical findings and laboratory biomarkers that reflect immunological and inflammatory activity. Current treatment strategies require a multidisciplinary approach aimed at controlling disease activity, preventing organ damage, and improving quality of life. Advances in research have contributed to better disease understanding, although limitations in early diagnosis and long-term management persist.
Conclusion: Systemic Lupus Erythematosus is a complex disease with significant physical, psychological, and social impact on affected individuals. Early recognition of symptoms and accurate diagnosis are essential to reduce morbidity and improve patient outcomes. Continuous research and comprehensive clinical care are fundamental to optimize disease management and enhance the quality of life of patients living with Systemic Lupus Erythematosus.

FullText HTML FullText PDF DOI: 10.37871/jbres2261 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2026 Bergamaschi MM. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Bergamaschi MM. Systemic Lupus Erythematosus: Clinical, Diagnostic, and Therapeutic Perspectives. J Biomed Res Environ Sci. 2026 Jan 24; 7(1): 11. Doi: 10.37871/jbres2261

Subject area(s)

RheumatologyInternal MedicineImmunology

References

  1. Souza RR, Barreto MS, Teston EF, Reis PR, Cecilio HPMC, Marcon SS. Duality of living with systemic lupus erythematosus: Fluctuating between good days and bad days. Texto Contexto Enferm. 2021;30:1-10. doi: 10.1590/1980-265x-tce-2020-0210.
  2. Günther C, Wenzel J. Lupus erythematosus. J Dtsch Dermatol Ges. 2023 Apr;21(4):426-430. doi: 10.1111/ddg.15049. PMID: 37070503.
  3. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 Sep;71(9):1400-1412. doi: 10.1002/art.40930. Epub 2019 Aug 6. PMID: 31385462; PMCID: PMC6827566.
  4. Ministério da Saúde. Clinical Protocol and Therapeutic Guidelines for Systemic Lupus Erythematosus. 2022.
  5. Souza RR, Marcon SS, Teston EF, Reis P, Seguraço RSCS, Silva ES, Giacon-Arruda BCC, Aquiles GJ. Influential factors on the quality of life of people with systemic lupus erythematosus. Acta Paul Enferm. 2021;34:1-10. doi: 10.37689/acta-ape/2021AO01173.
  6. Soares YV, Guerrieri CG, Pancoto JAT. Epidemiological profile of patients with systemic lupus erythematosus in the city of Vitória, Espírito Santo. Braz J Prod Eng. 2023; 9(1):144-159. doi: 10.47456/bjpe.v9i1.39945.
  7. Sales IM, Borges GM, Morais BP, Moreira FBL, Rocha LCP, Martins LRS, Silva MPB, Ribeiro RB, Muniz AFC, Cury IL. Systemic lupus erythematosus: Epidemiological, pathophysiological, and therapeutic management aspects. Braz J Health Rev. 2023;6(5):20242-20251.
  8. Santos FCC, Sousa FCL, Castro Junior JBC, Costa SDS. Mortality from systemic lupus erythematosus in Brazil: An analysis of the sociodemographic profile. Res Soc Dev. 2022;11(13):1-10. doi: 10.33448/rsd-v11i13.25968.
  9. Mathian A, Arnaud L, Amoura Z. Etiopathogenesis of systemic lupus erythematosus: A 2014 update. Rev Med Interne. 2014;35(8):503-511. doi: 10.1016/j.revmed.2013.10.334.
  10. Richez C, Lazaro E, Seneschal J, Couzi L. Systemic lupus erythematosus. EMC Aparelho Locomotor. 2024;57:1-20. doi: 10.1016/S1286-935X(24)49136-3.
  11. Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis. 2023 Aug;82(8):999-1014. doi: 10.1136/ard-2022-223741. Epub 2023 Feb 15. PMID: 36792346.
  12. Accapezzato D, Caccavale R, Paroli MP, Gioia C, Nguyen BL, Spadea L, Paroli M. Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Int J Mol Sci. 2023 Mar 31;24(7):6578. doi: 10.3390/ijms24076578. PMID: 37047548; PMCID: PMC10095030.
  13. Guffroy A, Jacquel L, Guffroy B, Martin T. CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy. Joint Bone Spine. 2024 Sep;91(5):105702. doi: 10.1016/j.jbspin.2024.105702. Epub 2024 Feb 7. PMID: 38336271.
  14. Waldheim E, Ajeganova S, Bergman S, Frostegård J, Welin E. Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study. Clin Rheumatol. 2018 Jul;37(7):1825-1834. doi: 10.1007/s10067-018-4079-1. Epub 2018 Apr 14. PMID: 29654486; PMCID: PMC6006213.
  15. Larsen JL, Hall EOC, Jacobsen S, Birkelund R. The existential experience of everyday life with systemic lupus erythematosus. J Adv Nurs. 2018 May;74(5):1170-1179. doi: 10.1111/jan.13525. Epub 2018 Feb 22. PMID: 29350776.
  16. Garces JPS, Guerra MCO, Salas Siado JÁ, Morales Marenco JJ. Systemic Lupus Erythematosus: general aspects of its pathophysiology, clinical features, diagnostic approach, and therapeutic management. Rev Parag Reumatol. 2023; 9(1):25-32. doi: 10.18004/rpr/2023.09.01.25.
  17. Luquetti CM, Alvarenga RM, Vasconcelos Filho GM, Hancke G, Leão MEDSA, Fadel SR, Santana VL, Palin GHB, Barreto GP, Grego JS, Diniz BB, Pereira TL, Maganhin CC. Systemic lupus erythematosus: clinical manifestations and diagnosis. Braz J Implantol Health Sci. 2024;6(8):5565-5576. doi: 10.36557/2674-8169.
  18. Silpa-Archa S, Lee J, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2015; 100(1):135-141. doi: 10.1136/bjophthalmol-2015-306629.
  19. Aviña-Zubieta JA, To F, Vostretsova K, De Vera M, Sayre EC, Esdaile JM. Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study. Arthritis Care Res (Hoboken). 2017 Jun;69(6):849-856. doi: 10.1002/acr.23018. Epub 2017 May 9. PMID: 28129475.
  20. Sandri JB, De Vargas GC, Araujo CIF, Da Silva ER, Mildemberger TS, Navarro SD, Ribeiro CNM, Ribas JLC. General aspects of systemic lupus erythematosus. Saúde Desenvolv. 2019.
  21. Nazaré KA, Leal WS, Fernandes EL, Silva FCS, Araújo MES, Melo DNA, Rodrigues BTF, Lopes LA. Systemic lupus erythematosus: Diagnostic methods and treatment strategies. Braz J Surg Clin Res. 2021;34(3):36-41.
  22. Yu H, Nagafuchi Y, Fujio K. Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus. Biomolecules. 2021 Jun 22;11(7):928. doi: 10.3390/biom11070928. PMID: 34206696; PMCID: PMC8301935.
  23. Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M. The Diagnosis and Treatment of Systemic Lupus Erythematosus. Dtsch Arztebl Int. 2015 Jun 19;112(25):423-32. doi: 10.3238/arztebl.2015.0423. PMID: 26179016; PMCID: PMC4558874.
  24. Fava A, Petri M. Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2019 Jan;96:1-13. doi: 10.1016/j.jaut.2018.11.001. Epub 2018 Nov 16. PMID: 30448290; PMCID: PMC6310637.
  25. Fan Y, Hao YJ, Zhang ZL. Systemic lupus erythematosus: year in review 2019. Chin Med J (Engl). 2020 Sep 20;133(18):2189-2196. doi: 10.1097/CM9.0000000000000983. PMID: 32810049; PMCID: PMC7508449.
  26. Zanevan IR, Abreu ACP, Marques APC, Drummond Júnior DG, Chagas JMA, Santos JV, Lobo TPM, Prates LS. Systemic lupus erythematosus: Limitations of the current classification and diagnostic perspectives. Braz J Health Rev. 2022;5(1):237-249. doi: 10.34119/bjhrv5n1-022.
  27. Macedo RM, Ribeiro Garcia T, Castanheira EP, Costa Noleto D, Freitas TVM, Freitas AA. Systemic lupus erythematosus: Relationship between different treatments and clinical outcomes. Rev Med (São Paulo). 2020; 99(6):573-580. doi: 10.11606/issn.1679-9836.v99i6p573-580.
  28. Ministério da Saúde. Recommendation report: Intravenous belimumab as an adjunctive treatment for adult patients with systemic lupus erythematosus. 2023.
  29. D’Araújo ALC, Conde MLCM, Magalhães RA, Maroñas PA, Chagas DRS, Coutinho SAMC. Role of Corticosteroids in the Treatment Of Systemic Lupus Erythematosus – Uses and Side Effects. Acta MSM. 2024;11(1):1-8.
  30. Aranow C, Allaart CF, Amoura Z, Bruce IN, Cagnoli PC, Chatham WW, Clark KL, Furie R, Groark J, Urowitz MB, van Vollenhoven R, Daniels M, Fox NL, Gregan YI, Henderson RB, van Maurik A, Ocran-Appiah JC, Oldham M, Roth DA, Shanahan D, Tak PP, Teng YO. Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study. Ann Rheum Dis. 2024 Oct 21;83(11):1502-1512. doi: 10.1136/ard-2024-225686. PMID: 39159997; PMCID: PMC11503042.
  31. Liang H, Tian X, Cao LY, Chen YY, Wang CM. Effect of psychological intervention on health-related quality of life in people with systemic lupus erythematosus: a systematic review. Int J Nurs Sci. 2014;1(3):298-305. doi: 10.1016/j.ijnss.2014.07.008.
  32. Blaess J, Geneton S, Goepfert T, Appenzeller S, Bordier G, Davergne T, Fuentes Y, Haglo H, Hambly K, Kinnett-Hopkins D, Su K-Y, Legge A, Li L, Mak A, Padjen I, Sciascia S, Sheikh SZ, Soriano-Maldonado A, Ugarte-Gil MF, Md Yusof Y, Parodis I, Arnaud L. Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus: consensus by an international task force. RMD Open. 2024;10(2):e004171.
  33. Sato EI. Systemic lupus erythematosus. Rev Bras Reumatol. 2008;29:651-662.
  34. Araújo ALPK, Paliares ICF, Araújo MIPK, Novo NF, Cadaval RAM, Martinez JE. Does the association between fibromyalgia and systemic lupus erythematosus (SLE) alter the presentation and severity of both diseases? Rev Bras Reumatol. 2015;55:37-42. doi: 10.1016/j.rbr.2014.08.004.
  35. Cal SFLM. Literature review on the efficacy of psychological interventions in the treatment of systemic lupus erythematosus. Psicol Teor Pesq. 2011;27(4):485-490. doi: 10.1590/S0102-37722011000400012.
  36. Souza RR, Marcon SS, Teston EF, Barreto MDS, Reis PD, Cecilio HPM, Marquete VF, Ferreira PC. From diagnosis to complications: experiences of those who live with systemic lupus erythematosus. Rev Bras Enferm. 2022 Apr 15;75(4):e20200847. English, Portuguese. doi: 10.1590/0034-7167-2020-0847. PMID: 35442302
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership